Xospata 40 mg
Xospata 40 mg is a medicine authorised by Swissmedic under authorisation number 67211. The authorisation holder is Astellas Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 24 September 2020 and the authorisation is valid without a time limit. ATC code L01EX13 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67211 |
|---|---|
| Name | Xospata 40 mg |
| Full name | Xospata 40 mg, Filmtabletten |
| Authorisation holder | Astellas Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EX13 |
| First authorisation | 24 September 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xospata 40 mg, Filmtabletten | A | 24 September 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 84 | Tablette(n) | L01EX13 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Xospata 40 mg authorised in Switzerland?
Yes. Xospata 40 mg is authorised by Swissmedic under authorisation number 67211, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Xospata 40 mg have?
Xospata 40 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Xospata 40 mg?
The authorisation holder is Astellas Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.